Sensorineural Hearing Loss Clinical Trial
Official title:
Comparison of Patient Satisfaction and Audiological Performance Between Neuro 1 and Neuro 2 Speech Processors
The present study aims to evaluate patient satisfaction and audiological performance with their current cochlear implant speech processor, the Neuro 1, and to compare it with the satisfaction and performance obtained with the new speech processor, the Neuro 2.
Nowadays, cochlear implants (CI) are successfully used to rehabilitate severe to profound sensorineural hearing loss. Oticon Medical recently developed a new cochlear implant system, including a new implantable internal part (Neuro Zti) and a new speech processor (Neuro 1). This new speech processor automatically detects and adapts to the sound environment, increasing the ease of listening in all situations. A second version of this speech processor has very recently been developed, called the Neuro 2. The Neuro 1 and 2 share the same signal processing characteristics and the "sound" delivered to the patient is similar. However, the Neuro 2 offers better ergonomics (smaller size and weight, rechargeable batteries…). Some improvements available on the Neuro 2 may be particularly interesting for children. The aim of the present study is twofold: 1. Compare the satisfaction of adult and pediatric users for the speech processor Neuro 1 with their satisfaction for the Neuro 2, and 2. Show that audiological outcomes are at least as good for the Neuro 2 than for the Neuro 1. The participants come at the hospital for three visits. The Neuro 1 is evaluated during the first visit (V1). Evaluation of the Neuro 2 takes place during the second (V2, 15 days after V1) and the third (V3, 3 months after V2). ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00023036 -
Clinical and Genetic Analysis of Enlarged Vestibular Aqueducts
|
||
| Completed |
NCT03746613 -
Clinal Evaluation of Navigation Based Functional Ear Surgery Using Image Guided and Robotically Assisted Techniques
|
N/A | |
| Recruiting |
NCT05568329 -
Appreciation for Music Processed by Hearing Aids
|
N/A | |
| Withdrawn |
NCT05061758 -
A Trial of LY3056480 in Patients With SNLH
|
Phase 2 | |
| Completed |
NCT01434446 -
The Effect of Sound Stimulation on Hearing Ability
|
N/A | |
| Completed |
NCT03212924 -
Listening Effort in Cochlear Implant Users
|
N/A | |
| Recruiting |
NCT06053190 -
Effects of Clear Speech on Listening Effort and Memory in Sentence Processing
|
N/A | |
| Completed |
NCT03718975 -
Quality Control of CE-Certified Phonak Hearing Aids - 2018_28
|
N/A | |
| Completed |
NCT06025097 -
Intra-Tympanic Steroid With PRP Combination in Sensorineural Hearing Loss and Tinnitus.
|
Early Phase 1 | |
| Recruiting |
NCT04102215 -
The Efficacy of a Minimally Invasive Direct Cochlear Access Via the HEARO Procedure
|
N/A | |
| Recruiting |
NCT04108598 -
The SeaSHeL National Prospective Cohort Study
|
||
| Active, not recruiting |
NCT04750642 -
Cochlear Implant With Dexamethasone Eluting Electrode Array
|
N/A | |
| Completed |
NCT04120116 -
FX-322 in Adults With Stable Sensorineural Hearing Loss
|
Phase 2 | |
| Recruiting |
NCT06223724 -
Status Telemetry for Cochlear Implantations
|
||
| Completed |
NCT02005822 -
Congenital Cytomegalovirus: Efficacy of Antiviral Treatment
|
Phase 3 | |
| Suspended |
NCT02616172 -
Autologous Bone Marrow Harvest and Transplant for Sensorineural Hearing Loss
|
Phase 1/Phase 2 | |
| Completed |
NCT02259595 -
Study to Determine the Safety, Tolerability, and Pharmacokinetic Profile of HPN-07 and HPN-07 Plus NAC
|
Phase 1 | |
| Unknown status |
NCT01902914 -
Effectiveness of P02 Digital Hearing Aids
|
Phase 1/Phase 2 | |
| Completed |
NCT00589511 -
Nucleus Freedom Cochlear Implant System Pediatric Post-approval Study
|
N/A | |
| Completed |
NCT04462198 -
Phase I/IIa Study Evaluating Safety and Efficacy of an Intratympanic Dose of PIPE-505 in Subjects With Hearing Loss
|
Phase 1/Phase 2 |